ASST-Papa Giovanni XXIII
Bergamo, MILANO, 24127, Italy
Location status: Recruiting
NCT Number: NCT06342557
The study is part of the MACROLIVER Project, whose main objective is to create a digital tool for patients and caregivers for the management of liver disease that allows the optimization of therapy and/or the treatment process, even remotely. Such a tool not only reduces the movement of patients who are by definition fragile, but also enables the optimization of access and care by a multidisciplinary team. This tool is intended to support doctors and patients, but in no way replaces normal clinical practice. This study aims to explore the specificities of patients experiencing the transition from the pediatric ward to the adult ward in order to identify risk and protective factors that influence psychological well-being at both an individual and relational level. In order to gather all the information about the patients attending the transitional clinic and to obtain a more complete and truthful clinical-psychological picture, the study also includes the collection of retrospective data of the transplanted patients.
Interested in participating?
Request Info14 year–20 year
All sexes
Observational
Bergamo, MILANO, 24127, Italy
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 3 months
MGLS is used to assess non-adherence to therapy. The MGLS includes four questions with yes/no response options, resulting in a score from 0 to 4. Based on this score, there are 3 levels of adherence: high, medium and low adherence with 0, 1-2 and 3-4 points respectively. Scores below 2 indicate a lack of adherence to therapy, while scores greater than or equal to 3 indicate adherence to therapy.
Contact information is provided by the study sponsor or research team.
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Other
Integrated System for Patients Who Belong the Transition to Adult Services and Are Undergoing a Liver Transplant
Acronym: MACROLIVER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06280950
Liver Transplant
Phoenix, Arizona, United States
View Trial DetailsNCT06075745
Liver Transplant
Birmingham, Alabama, United States
View Trial DetailsNCT07549503
Liver Transplant
San Francisco, California, United States
View Trial DetailsNCT07519057
Digestive System Diseases, End Stage Liver Disease
Warsaw, Poland
View Trial Details